PEG‐asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|3|427-433

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.3, 2015-03, pp. : 427-433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The circadian schedule for childhood acute lymphoblastic leukemia maintenance therapy does not influence event‐free survival in the NOPHO ALL92 protocol

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 4, 2014-04 ,pp. : 653-658

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 65, Iss. 3, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

L‐Asparaginase lowers plasma antithrombin and mannan‐binding‐lectin levels: Impact on thrombotic and infectious events in children with acute lymphoblastic leukemia

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 8, 2015-08 ,pp. : 1381-1387

John Wiley & Sons Inc

Access to resources Recommend Favorite

Individualized 6‐mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trial

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 1, 2018-01 ,pp. : 53-60

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cerebrospinal Fluid Excitatory Amino Acids and Tau Protein in Children with Acute Lymphoblastic Leukemia Treated according to the BFM Protocol

By  

Acta Haematologica, Vol. 112, Iss. 4, 2004-11 ,pp. : 222-224

Karger

Access to resources Recommend Favorite